Unbiased AI-powered news
A startup has developed a technique to preserve the human brain following death. The method aims to maintain brain structure for potential future revival. This development raises practical and philosophical questions about its implications.
Substrate placeholder — needs reviewA startup has announced a method to preserve the human brain after death. According to reports, this preservation could enable future technologies to restore brain function.
The startup's approach focuses on rapid intervention post-mortem to protect brain tissue from decay. The goal is to create a viable state for potential uploading or revival in advanced systems.
The development prompts discussions on practical challenges, including legal frameworks for post-death procedures.
Philosophical questions arise regarding the definition of death and personal identity.
While the technique represents progress, full revival remains a distant possibility dependent on advancements in neuroscience and computing.
Single source — no framing comparison available.
upi.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. Manufactured by Merck, the pill inhibits PCSK9 and cut LDL levels by up to 60 percent in a 24-week trial of 2,912 participants. It carries a list price of $315 for a 30-day supply and will reach…
washingtonpost.comFlooding along the Guadalupe River has killed at least one person in central Texas. The same area recorded more than 130 deaths in flash floods last summer. Governor Greg Abbott confirmed the fatality in a Thursday update.
dailywire.comKalshi will allow bets on selected clinical trial results and full FDA decisions, starting with Phase 3 studies from established companies. The FDA separately approved Merck's Lipfendra cholesterol pill based on studies showing up to 60% LDL reduction.